A multi-center, open-label, unilateral interaction study of UCB 34714 on stable phenytoin monotherapy during a 45 day b.i.d. administration period in 15 adult subjects suffering from epilepsy.

Trial Profile

A multi-center, open-label, unilateral interaction study of UCB 34714 on stable phenytoin monotherapy during a 45 day b.i.d. administration period in 15 adult subjects suffering from epilepsy.

Completed
Phase of Trial: Phase I

Latest Information Update: 30 Oct 2014

At a glance

  • Drugs Brivaracetam; Phenytoin
  • Indications Epilepsy
  • Focus Pharmacokinetics
  • Sponsors UCB
  • Most Recent Events

    • 16 Jul 2007 Status changed from in progress to completed.
    • 20 Feb 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top